Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Resistance in Advanced Breast Cancer Patients

Clinical trial NCT05452213 · RECRUITING

Trial details

NCT number: NCT05452213
Sponsor: Institut fuer Frauengesundheit
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Breast Cancer Breast Neoplasms Breast Neoplasm Female Breast Cancer Female HER2-negative Breast Cancer Hormone Receptor-positive Breast Cancer Advanced Breast Cancer

Start date: 2022-10-12
Primary completion: 2024-10-01
Enrollment: 1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.